Evidence map›Paper›PMID 33584498›Full record

ReviewFrontiers in neurology2020

Deep Brain Stimulation Initiative: Toward Innovative Technology, New Disease Indications, and Approaches to Current and Future Clinical Challenges in Neuromodulation Therapy.

Yanan Sui, Ye Tian, Wai Kin Daniel Ko, Zhiyan Wang, Fumin Jia, Andreas Horn, Dirk De Ridder, Ki Sueng Choi, Ausaf A Bari, Shouyan Wang and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 8 countries.

Yanan SuiNational Engineering Laboratory for Neuromodulation, Tsinghua University, Beijing, China.
Ye TianNational Engineering Laboratory for Neuromodulation, Tsinghua University, Beijing, China.
Wai Kin Daniel KoNational Engineering Laboratory for Neuromodulation, Tsinghua University, Beijing, China.
Zhiyan WangNational Engineering Laboratory for Neuromodulation, Tsinghua University, Beijing, China.
Fumin JiaNational Engineering Laboratory for Neuromodulation, Tsinghua University, Beijing, China.
Andreas HornCharité, Department of Neurology, Movement Disorders and Neuromodulation Unit, University Medicine Berlin, Berlin, Germany.
Dirk De RidderSection of Neurosurgery, Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Ki Sueng ChoiDepartment of Psychiatry and Behavioural Science, Emory University, Atlanta, GA, United States.
Ausaf A BariDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, United States.
Shouyan WangInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.
Clement HamaniHarquail Centre for Neuromodulation, Sunnybrook Research Institute, Toronto, ON, Canada.
Kenneth B BakerDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Andre G MachadoDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Tipu Z AzizDepartment of Neurosurgery, John Radcliffe Hospital, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Erich Talamoni FonoffDepartment of Neurology, University of São Paulo Medical School, São Paulo, Brazil.
Andrea A KühnCharité, Department of Neurology, Movement Disorders and Neuromodulation Unit, University Medicine Berlin, Berlin, Germany.
Hagai BergmanDepartment of Medical Neurobiology (Physiology), Institute of Medical Research-Israel-Canada (IMRIC), Faculty of Medicine, Jerusalem, Israel.
Terence SangerUniversity of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Hesheng LiuDepartment of Neuroscience, College of Medicine, Medical University of South Carolina, Charleston, SC, United States.
Suzanne N HaberDepartment of Pharmacology and Physiology, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States.
Luming LiNational Engineering Laboratory for Neuromodulation, Tsinghua University, Beijing, China.
Tsinghua University · CNCharité - Universitätsmedizin Berlin · DEChildren's Hospital of Los Angeles · USCleveland Clinic · USCleveland Clinic Lerner College of Medicine · USHadassah Medical Center · ILHarvard University · USHospital Sírio-Libanês · BRIcahn School of Medicine at Mount Sinai · USMedical University of South Carolina · USShanghai Center for Brain Science and Brain-Inspired Technology · CNSunnybrook Hospital · CAUniversity of California, Los Angeles · USUniversity of Otago · NZUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep brain stimulation (DBS) is one of the most important clinical therapies for neurological disorders. DBS also has great potential to become a great tool for clinical neuroscience research. Recently, the National Engineering Laboratory for Neuromodulation at Tsinghua University held an international Deep Brain Stimulation Initiative workshop to discuss the cutting-edge technological achievements and clinical applications of DBS. We specifically addressed new clinical approaches and challenges in DBS for movement disorders (Parkinson's disease and dystonia), clinical application toward neurorehabilitation for stroke, and the progress and challenges toward DBS for neuropsychiatric disorders. This review highlighted key developments in (1) neuroimaging, with advancements in 3-Tesla magnetic resonance imaging DBS compatibility for exploration of brain network mechanisms; (2) novel DBS recording capabilities for uncovering disease pathophysiology; and (3) overcoming global healthcare burdens with online-based DBS programming technology for connecting patient communities. The successful event marks a milestone for global collaborative opportunities in clinical development of neuromodulation to treat major neurological disorders.

Indexed as

deep brain stimulationdepressiongait disabilityMRI compatibilityneuromoxdulation

Identifiers

PMID33584498
PMCPMC7876228
OpenAlexW3126564746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.